Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder

The α(2)-adrenergic receptor agonist guanfacine, in its extended-release formulation (GXR), is the most recent nonstimulant medication approved in several countries for the treatment of attention-deficit hyperactivity disorder (ADHD) as monotherapy and as adjunctive pharmacotherapy to stimulants in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropsychiatr Dis Treat
Hlavní autoři: Martinez-Raga, Jose, Knecht, Carlos, de Alvaro, Raquel
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4455846/
https://ncbi.nlm.nih.gov/pubmed/26064054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S65735
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky